文献速递糖尿病肥胖与代谢综合征

FGF21在不改变体脂的情况下改善肥胖易感糖尿病小鼠模型的血糖稳态

FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes.
PubMed 文献 · Diabetologia · 2017-08-02

研究旨在检验外源性成纤维细胞生长因子21(FGF21)能否预防新西兰肥胖(NZO)小鼠的糖尿病和β细胞丢失,该小鼠为多基因肥胖和2型糖尿病模型。雄性NZO小鼠接受特殊饮食方案并在1周内发生糖尿病,皮下注射PBS或FGF21后评估血糖稳态等指标。FGF21治疗防止了胰岛破坏和高血糖发生,并改善葡萄糖清除,但体脂未减少。

要点

  • FGF21治疗防止了NZO小鼠的胰岛破坏和高血糖发生,并改善葡萄糖清除。
  • FGF21通过诱导皮下白色脂肪组织褐变增加能量消耗。
  • FGF21治疗未降低体脂,但皮下白色脂肪组织Glut4表达升高。

核心结论

  • FGF21可预防饮食诱导的糖尿病发生,且不改变体脂量;有益效应通过白色脂肪组织褐变和产热升高介导;数据表明肥胖不诱导NZO小鼠的FGF21抵抗。

研究设计与样本

  • 雄性NZO小鼠接受特殊饮食方案,该方案在1周内导致糖尿病发生。
  • 小鼠皮下注射PBS或FGF21,评估血糖稳态、能量消耗、食物摄入及其他代谢终点。

主要发现

  • FGF21治疗防止了胰岛破坏和高血糖发生,并改善葡萄糖清除。
  • FGF21通过诱导皮下白色脂肪组织褐变增加能量消耗。
  • 由于代偿性食物摄入增加,FGF21治疗未使体脂减少,但皮下白色脂肪组织Glut4表达升高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Fibroblast growth factor 21 (FGF21) is considered to be a promising therapeutic candidate for the treatment of type 2 diabetes. However, as FGF21 levels are elevated in obese and diabetic conditions we aimed to test if exogenous FGF21 is sufficient to prevent diabetes and beta cell loss in New Zealand obese (NZO) mice, a model for polygenetic obesity and type 2 diabetes. METHODS: Male NZO mice were treated with a specific dietary regimen that leads to the onset of diabetes within 1 week. Mice were treated subcutaneously with PBS or FGF21 to assess changes in glucose homeostasis, energy expenditure, food intake and other metabolic endpoints. RESULTS: FGF21 treatment prevented islet destruction and the onset of hyperglycaemia, and improved glucose clearance. FGF21 increased energy expenditure by inducing browning in subcutaneous white adipose tissue. However, as a result of a compensatory increased food intake, body fat did not decrease in response to FGF21 treatment, but exhibited elevated Glut4 expression. CONCLUSIONS/INTERPRETATION: FGF21 prevents the onset of diet-induced diabetes, without changing body fat mass. Beneficial effects are mediated via white adipose tissue browning and elevated thermogenesis. Furthermore, these data indicate that obesity does not induce FGF21 resistance in NZO mice.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Laeger T, Baumeier C, Wilhelmi I, et al. FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes. Diabetologia. 2017. PMID: 28770320. doi:10.1007/s00125-017-4389-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。